PharmaResearch
Financials
Valuation Metrics
PharmaResearch's Market Cap is ₩3.4T. At end of 2025 it was ₩4.2T. Ranked #139 of 2,421 in KR market (top 6%), #18 of 1,640 on KOSDAQ (top 1%), #10 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 4%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 3.40T KRW | KR#139/2,421 Sec#10/231 |
| Revenue | 603.58B KRW | KR#556/2,421 Sec#25/231 |
| Net Income | 195.16B KRW | KR#153/2,421 Sec#8/231 |
| Total Assets | 1.11T KRW | KR#454/2,421 Sec#25/231 |
| Net Assets | 788.87B KRW | KR#351/2,421 Sec#23/231 |
| Employees | 436 | KR#564/2,421 Sec#45/231 |
| Value | ||
| P/E | 17.41x | KR#1,115/2,421 Sec#67/231 |
| P/B | 4.31x | KR#2,208/2,421 Sec#185/231 |
| PEG | 0.28x | KR#619/2,421 Sec#35/231 |
| P/S | 5.63x | KR#2,172/2,421 Sec#144/231 |
| EV/EBITDA | 13.40x | KR#787/2,421 Sec#45/231 |
| FCF Yield | 4.52% | KR#882/2,421 Sec#49/231 |
| Profitability | ||
| ROE | 24.74% | KR#105/2,421 Sec#8/231 |
| ROA | 17.63% | KR#74/2,421 Sec#6/231 |
| Op. Margin | 39.36% | KR#27/2,421 Sec#6/231 |
| Revenue Growth | 34.19% | KR#338/2,421 Sec#34/231 |
| Earnings Growth | 61.22% | KR#511/2,421 Sec#34/231 |
| Financial Health | ||
| Debt Ratio | 40.35% | KR#797/2,421 Sec#93/231 |
| Total Debt | 6.51B KRW | KR#1,742/2,421 Sec#163/231 |
| FCF | 153.44B KRW | KR#136/2,421 Sec#5/231 |
| Cash | 220.29B KRW | KR#243/2,421 Sec#8/231 |
| Current Ratio | 7.72x | KR#153/2,421 Sec#33/231 |
| Net Debt/EBITDA | -0.90x | KR#405/2,421 Sec#22/231 |
| Dividend | ||
| Div. Yield | 1.13% | KR#1,086/2,421 Sec#61/231 |
| Div. Growth | 236.36% | KR#40/2,421 Sec#1/231 |
| Performance | ||
| 1Y Return | -46.22% | KR#1,973/2,421 Sec#172/231 |
| 1M Return | -16.37% | KR#2,268/2,421 Sec#197/231 |
| From 52W High | -52.75% | KR#1,523/2,421 Sec#118/231 |
| 1Y MDD | -60.34% | KR#1,495/2,421 Sec#121/231 |
| Trading | ||
| Volume | 84,397 shares | KR#866/2,421 Sec#84/231 |
| Trading Value | 27.62B KRW | KR#128/2,421 Sec#8/231 |
| Foreign Own. | 11.09% | KR#438/2,421 Sec#34/231 |
| Per Share | ||
| EPS | 18,784 KRW | KR#55/2,421 Sec#2/231 |
| BPS | 75,929 KRW | KR#180/2,421 Sec#10/231 |
Company Info
PharmaResearch was founded in 2001 as a pharmaceutical and medical device development and consulting company, later establishing a GMP-certified factory in 2013 and completing its second factory in 2019. As a biopharmaceutical company, it researches, manufactures, and sells pharmaceuticals, medical devices, and cosmetics for various medical fields, including dermatology and orthopedics. Leveraging its technological competitiveness, the company is committed to R&D and market expansion, pursuing global business by entering Asian, European, and North American markets. PharmaResearch was established in 2001 and is headquartered in Gangneung-si, Gangwon-do.